The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
With $16 million gift, Columbia will open a new center for Lyme and other tick-borne diseases this summer, offering patients specialized care and expanding research at a national level.
SARS-CoV-2, the virus that causes COVID-19, does not infect brain cells but can inflict significant neurological damage, according to a new study of dozens of deceased patients.
With more patients complaining of lingering and chronic effects from COVID-19, Columbia experts review what’s known and why care for long-haulers requires an interdisciplinary approach.
Kellie Bryant, DNP, and Robert Fullilove, EdD, discussed myths and facts about the COVID-19 vaccine at a virtual event organized by the Williamsbridge branch of the NAACP.
A real-time study of immune responses inside the lungs of COVID patients suggests a cytokine “hurricane” in the airways drives severe disease, and an influx of T cells may be critical to survival.
New videos from Hip Hop Public Health, a community organization founded by a Columbia neurologist, are using the power of music to help increase COVID-19 vaccine coverage in communities of color.
Jessica Justman, MD, an infectious disease specialist and epidemiologist at Columbia, says vaccinated people still need to take some precautions for now.
A virtual town hall hosted by CUIMC and NewYork-Presbyterian Hospital brought together community health workers and local leaders to discuss questions and concerns regarding the COVID-19 vaccines.